Top news of the week: 09.06.2020.
#biotechnology #CoronaOutbreak #COVID19 #CoronaPandemic #biospace #lifesciences #pharmaceuticals #CoronaVirus #lifescience #marketing
Companies And Industries
As #lifescience professionals, we handle hard science and research everyday. But we're also confronted with business-related tasks, such as starting conversations with our audiences. Here is a guide to help you level up your life science #marketing skills!
https://t.co/e9Fj8C2jkP
OpenThe Beginner’s Guide to Biotech & Life Science Marketing
As life science professionals, we not only continuously handle hard science and research, but we also have to learn how to market our products and interact with a large online audience. ...
The Dish’s Weekly Biotechnology News Wrap Up – June 5, 2020
This week's headlines include: Trump administration selects five coronavirus vaccine candidates as finalists: NYT, Fauci: Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will ...
Pharma sees more post-M&A rebrands than other industries—and it does them better, too https://t.co/MYBhX7A2MH
OpenPharma sees more post-M&A rebrands than other industries—and it does them better, too
To rebrand or not? It’s a big question for pharma companies before and after acquisitions—and one answered with "yes" more often than in other industries. Pharma, in fact, was the most ...
Legend leads active day for Nasdaq biopharma IPOs
American depositary shares in CAR T-focused Legend Biotech Corp. (NASDAQ:LEGN), offered in a red hot IPO at $23 each, took off Friday, rising 60.9% to close at $37 per share. Other ...
Biopharma Update on the Novel Coronavirus: June 8
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/pWPZk4cQz1
OpenBiopharma Update on the Novel Coronavirus: June 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
Daiichi's biotech unit Plexxikon snaps up BRAF cancer drug from Novellus https://t.co/4nHH1jkc83 https://t.co/gc7Hjf2KI6
OpenDaiichi's biotech unit Plexxikon snaps up BRAF cancer drug from Novellus
Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394.
Biopharma Update on the Novel Coronavirus: June 3
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/WEfaz75kIC
OpenBiopharma Update on the Novel Coronavirus: June 3
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 3, 2020.
Biopharma Update on the Novel Coronavirus: June 4
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/XYvUu8bTCF
OpenBiopharma Update on the Novel Coronavirus: June 4
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 4, 2020.